Literature DB >> 11262461

Temporal changes in rates and reasons for medical induction of term labor, 1980-1996.

B P Yawn1, P Wollan, K McKeon, C S Field.   

Abstract

OBJECTIVE: This study was undertaken to assess temporal changes in rates and reasons for medical induction of term labor. STUDY
DESIGN: A retrospective medical record review was conducted on a population-based cohort of 1293 women with term deliveries.
RESULTS: The rate of medical labor induction increased from 12.9% in 1980 to 25.8% in 1995. Stated indications also changed, with a 2-fold increase in induction for postdate gestation, a 23-fold increase in induction for macrosomia, a 15-fold increase in elective induction, and a 22-fold decline in induction for premature rupture of membranes. The average gestational age at delivery of postdate pregnancies declined from 41.9 weeks in 1980 to 41.0 weeks in 1995. By 1995, the average maternal length of stay and the percentage of cesarean deliveries were higher among women with induced labor at term than among those with spontaneous labor at term.
CONCLUSION: Induction of term labor has almost doubled in prevalence during the past 15 years. The most common indications are elective induction and postdate pregnancy, often applied to gestations of 40 to 41 weeks' duration.

Entities:  

Mesh:

Year:  2001        PMID: 11262461     DOI: 10.1067/mob.2001.110292

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

Review 1.  Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).

Authors:  Philippa Middleton; Emily Shepherd; Vicki Flenady; Rosemary D McBain; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2017-01-04

2.  A Native American community with a 7% cesarean delivery rate: does case mix, ethnicity, or labor management explain the low rate?

Authors:  Lawrence Leeman; Rebecca Leeman
Journal:  Ann Fam Med       Date:  2003 May-Jun       Impact factor: 5.166

3.  The association between temporal changes in the use of obstetrical intervention and small-for-gestational age live births.

Authors:  Amy Metcalfe; Sarka Lisonkova; K S Joseph
Journal:  BMC Pregnancy Childbirth       Date:  2015-09-29       Impact factor: 3.007

4.  Outcome of misoprostol and oxytocin in induction of labour.

Authors:  Trishna Acharya; Ramesh Devkota; Bimbishar Bhattarai; Radha Acharya
Journal:  SAGE Open Med       Date:  2017-03-23

5.  Maternal exposure to ambient fine particulate matter and risk of premature rupture of membranes in Wuhan, Central China: a cohort study.

Authors:  Kun Wang; Yu Tian; Huabo Zheng; Shengshuai Shan; Xiaofang Zhao; Chengyun Liu
Journal:  Environ Health       Date:  2019-11-14       Impact factor: 5.984

6.  Induction of Labor in Primigravid Term Pregnancy with Misoprostol or Dinoprostone: A Comparative Study.

Authors:  Rizwana Arif; Tayaba Mazhar; Mashal Jamil
Journal:  Cureus       Date:  2019-09-24

7.  A parsimonious explanation for intersecting perinatal mortality curves: understanding the effect of plurality and of parity.

Authors:  KS Joseph; Shiliang Liu; Kitaw Demissie; Shi Wu Wen; Robert W Platt; Cande V Ananth; Susie Dzakpasu; Reg Sauve; Alexander C Allen; Michael S Kramer
Journal:  BMC Pregnancy Childbirth       Date:  2003-06-02       Impact factor: 3.007

8.  A parsimonious explanation for intersecting perinatal mortality curves: understanding the effects of race and of maternal smoking.

Authors:  K S Joseph; Kitaw Demissie; Robert W Platt; Cande V Ananth; Brian J McCarthy; Michael S Kramer
Journal:  BMC Pregnancy Childbirth       Date:  2004-04-16       Impact factor: 3.007

9.  Comparison of misoprostol and dinoprostone for elective induction of labour in nulliparous women at full term: a randomized prospective study.

Authors:  Evangelos G Papanikolaou; Nikos Plachouras; Aikaterini Drougia; Styliani Andronikou; Christina Vlachou; Theodoros Stefos; Evangelos Paraskevaidis; Konstantinos Zikopoulos
Journal:  Reprod Biol Endocrinol       Date:  2004-09-27       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.